Close
  Indian J Med Microbiol
 

Figure 2: (a) Effect of various doses of zoledronic acid on the percentage change in lumbar spine bone mineral density over 1 year (data is depicted as mean ± standard deviation). (b) Effect of various doses of zoledronic acid on plasma C-terminal telopeptide of type I collagen (β-CTX) over 1 year (data is depicted as median with inter-quartile range). (c) Effect of various doses of zoledronic acid on plasma procollagen type I N-terminal propeptide (P1NP) over 1 year (data is depicted as median with inter-quartile range). The plasma β-CTX and P1NP were lower at 6 months and 12 months compared to baseline in both groups (P < 0.001)

Figure 2: (a) Effect of various doses of zoledronic acid on the percentage change in lumbar spine bone mineral density over 1 year (data is depicted as mean ± standard deviation). (b) Effect of various doses of zoledronic acid on plasma C-terminal telopeptide of type I collagen (β-CTX) over 1 year (data is depicted as median with inter-quartile range). (c) Effect of various doses of zoledronic acid on plasma procollagen type I N-terminal propeptide (P1NP) over 1 year (data is depicted as median with inter-quartile range). The plasma β-CTX and P1NP were lower at 6 months and 12 months compared to baseline in both groups (<i>P</i> < 0.001)